Kenneth S. Cohen to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Kenneth S. Cohen has written about Dose-Response Relationship, Drug.
Connection Strength
0.025
-
Therapeutic targeting of a stem cell niche. Nat Biotechnol. 2007 Feb; 25(2):238-43.
Score: 0.013
-
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol. 2005 Nov 01; 23(31):8136-9.
Score: 0.012